Showing posts with label GlaxoSmithKline. Show all posts
Showing posts with label GlaxoSmithKline. Show all posts

Tuesday, February 17, 2015

Are you ready for first quarter-end close?

Be Ready for First Quarter-End Close and Earnings Announcements!

Your time is valuable, that's why this year's Gross-to-Net Accounting Forum is moving to a JAM-PACKED, one-day summit on March 23rd - minimizing the disruption to your work week.

Get a comprehensive overview of the entire pharmaceutical GTN process and minimize liability impacting your bottom line with industry experts such as:

• Amy Ramazio, Finance Director, GlaxoSmithKline
• Mila Tartakovsky, Sr. Director, Corporate Financial Analytics, Daiichi Sankyo
• Larry Breen, Director of Revenue Analytics, Sunovion Pharmaceuticals
• And more!

Download the agenda for more details and speaker line-ups.

Plus! Tailored Discussion Groups are back! Brainstorm issues, concepts and solutions related to your company size and function in the Gross-to-Net Roundtable Wine and Dinner.

Join us March 23, 2015 in Arlington and click here to register now.

If you have any questions about the event, please reach out to me at rgeswell@iirusa.com 






Friday, September 12, 2014

Last Chance to Register for MDRP 2014

Hurry! There is still time left to register for the
19th Annual Medicaid Drug Rebate Program Summit!
Online registration closes this Sunday, September 14th.
Register Now >>
 
 
MDRP 2014 begins in just 4 days! Don't miss out on THE authoritative event for everything government pricing, rebates and regulation. Join 70+ speakers, 500+ MDRP executives, 20+ solution providers in the only event where the government programs and pricing industry comes together each year to debate and create a roadmap to operational solutions.

Don't miss out on these key highlights on the MDRP 2014 agenda:

• 2 Keynote speakers discussing the true impact of the ACA and Medicaid reform
• Legal & Compliance Track dedicated to overcoming challenges in the current legal landscape and ensuring compliance with government program mandates affecting manufacturers
• CLE Accreditation - Earn continuing Legal Education (CLE) credits
• Four pharma case studies from AstraZeneca, Mylan and GSK
• Pre-conference workshop dedicated to Generic Drug Manufacturers
• Direct access to State Rebating Representatives in State Dispute Resolution Meetings
• And more!
 
 
Online registration will close Sunday, September 14th so register now! Remember to take an extra $100 off registration rates with the code XP1958BLOG. On-site registration will be available all three days of the conference.

Don't miss out! Be part of the go-to industry event and leave armed with the tools and ideas to optimize your government pricing operations.





Tuesday, July 29, 2014

MDRP Lifetime Achievement Award

Each year the MDRP audience selects who should receive the “Lifetime Achievement Award.” Nominations are now open. Make sure to get your choice in for consideration now.


As the longest running MDRP conference, we are honoring the best and recognizing the dedication of those who have propelled this industry forward. Please submit your award nomination(s) here. We have divided the nominations by role in the industry, as so many have worked together to make the Medicaid Drug Rebate Program what it is today. The deadline for nominations is Monday, August 11, 2014 and the winners will be announced at the event during the networking reception on Tuesday, September 16th - So make sure you register to attend the event now. Save $300 when you register by 8/8 with the code XP1958BLOG.

To learn more about the program, download the brochure now. 

See you in Chicago this September!




Wednesday, July 23, 2014

340B Entities: Best Practices for Pricing and Compliance Methodologies


Above, you will hear John Shakow, Partner, King & Spalding speaking with MDRP TV about 340B Entities – and the best practices for pricing and compliance methodologies. To hear more insights from John, join him at MDRP 2014, where he will be speaking again. Below you can find a highlight of one of his sessions at the event.

Understand the Implications: A Business Perspective
You’ve heard the presentations and the speeches, the panels and the analysis. In this session of the conference, we will try to tie it all together and give you a 360° view of the government pricing landscape in the coming year. The emphasis will be on key takeaways, which you and your colleagues should keep top of mind as you head back home. 2014–15 promises to be a year of great change and increasing complexity in all aspects of government pricing, and with that come the inevitable compliance, legal, business and operational challenges. Secure the benefits of MDRP 2014 with this roundup of highlights and key observations.

For more session information, download the complete agenda.

And remember as a blog reader you save an extra $100 off the current rate when you register with the code XP1958BLOG - Register by 8/8 to save a total of $300!

See you in Chicago!




Monday, June 2, 2014

MDRP 2014 Brochure Now Available - Plus 2013 Highlights



"I love MDRP, it is the Super Bowl of conferences for this space"


MDRP 2014 is back in Chicago this September and just in time to provide you with essential regulatory updates surrounding the impact of the ACA and AMP Final Rule.

Year after year, MDRP Chicago has continued to be THE authoritative MDRP event for everything government pricing, regulations, and rebates. It's the largest event in the space with the most speakers and government representation from CMS, HRSA, OIG, and more. Join 550+ MDRP executives at the event where the industry pauses to attend and get the most comprehensive educational experience over three days.

New for 2014!
• 2 Keynote speakers discussing the true impact of the ACA and Medicaid reform
• Legal & Compliance Track dedicated to overcoming challenges in the current legal landscape and ensuring compliance with government program mandates affecting manufacturers
• CLE Accreditation - Earn continuing Legal Education (CLE) credits
• Four pharma case studies from AstraZeneca, Mylan and GSK
• Pre-conference workshop dedicated to Generic Drug Manufacturers   

Download the 2014 Brochure

Register Now to Save up to $400! Plus take an EXTRA $100 off the current rate when you use the code XP1958BLOG – That is $500 in total savings.
This is the place to be in September. Stay ahead of the curve by getting the best networking, education, and technology at IIR's MDRP Summit. 
Enhanced by Zemanta




Thursday, May 29, 2014

Q&A with Amy Ramazio of GlaxoSmithKline – A Speaker at IIR’s Gross-to-Net Accounting Forum


At IIR's 2nd Annual Gross-to-Net Accounting Pharmaceutical Manufacturers, Amy Ramazio, Finance Director at GlaxoSmithKline will be the Big Pharma Chairperson, in our all new tailored discussion groups for your specific company size and function!

Below Amy sat down to do a quick Q&A session with us...enjoy!


Q&A:

1. How feasible is collaboration between managed markets, commercial, government programs and Finance?


Successful collaboration will largely depend on the particular individuals involved.  The key is for everyone to have an enterprise view.

2. Key questions to ask before investing and building an automated GTN system?

- What functionality is most important to your organization?
- How much are you willing to invest?
- When do you need the system to go live?


3. How to accrue and forecast patient/ payer related items? What critical/essential information is required and what aspects you can’t afford to overlook.


Forecasting and accruals are typically based on past history with some adjustments where there are specific changes expected in the future.  Having information to develop these adjustments is critical and could include: segment lives and expected trends, TRX data, formulary changes, legislation changes.   


To hear more from Amy, please join us in Philadelphia, June 17-18 for the 2nd Annual Gross-to-Net Accounting Forum. Plus register with the code XP1911BLOG to receive $100 off the current rate!

Register Now!